Listed by the USPTO as CERIONI, DANIEL LEE
Tech Center 3700 • Art Units: 3736 3791 3792
This examiner grants 64% of resolved cases
CERIONI, DANIEL LEE works in tech center 3700 and art unit 3736. The profile records 788 resolved cases, a 64.3% allowance rate, and a 1293-day median to allowance. The 28.0% interview lift indicates that interviews have been associated with improved allowance outcomes in the recorded cases.
The listed companies are Abbott Laboratories, Cardinal Health Inc., and GE Precision Healthcare LLC. The leading firms are AMPACC Law Group PLLC, BUCHANAN INGERSOLL & ROONEY PC, and Dentons Durham Jones Pinegar. The allowance rate and interview measure support active engagement, while the median time to allowance indicates that counsel should plan for continued prosecution and preserve flexibility in amendment strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18782190 | OXYGEN MEASUREMENT DEVICE AND OXYGEN MEASUREMENT SYSTEM | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18984393 | COUGH MONITORING METHOD AND RELATED DEVICE | Non-Final OA | Huawei Technologies Co., Ltd. |
| 18319359 | STIMULATION SYSTEM | Non-Final OA | Alphatec Spine, Inc. |
| 18938592 | NEONATAL POD WITH CHARGER | Final Rejection | GE Precision Healthcare LLC |
| 18499118 | PHYSIOLOGICAL SENSOR AND SENSING METHOD WITH SENSOR LIFT DETECTION | Non-Final OA | GE Precision Healthcare LLC |
| 18647171 | METHOD FOR ESTIMATING A BODY SURFACE AREA OF A SUBJECT AND MEDICAL IMAGING DEVICE | Non-Final OA | Siemens Healthineers AG |
| 18710896 | Implant Arrangement Enabling Virtual Programming of an Implant | Final Rejection | BIOTRONIK SE & Co. KG |
| 19109478 | IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY | Non-Final OA | Medtronic Ireland Manufacturing Unlimited Company |
| 18135837 | Blood Saving Blood Collection Device | Non-Final OA | Becton, Dickinson and Company |
| 18117765 | Blood Access Device with Integrated Blood Diagnostics | Final Rejection | Becton, Dickinson and Company |
| 18724814 | BLOOD GLUCOSE METER | Non-Final OA | PHC Holdings Corporation |
| 18979814 | Methods And Kits For Assessing Central Nervous System Integrity | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 19106737 | BIOLOGICAL SAMPLE COLLECTION SYSTEM WITH TWIST-ACTIVATED VALVE FOR SAMPLE RELEASE | Non-Final OA | DNA GENOTEK INC. |
| 17416431 | METHOD FOR EVALUATING USAGE DATA | Final Rejection | Otto Bock Healthcare Products GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.3% of resolved applications examined by Daniel Lee Cerioni were allowed (788 resolved cases), compared with 55.8% across Art Unit 3736 over the last five years.
This examiner's interview lift is +28.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Daniel Lee Cerioni took 1,293 days on average from filing to allowance.
Daniel Lee Cerioni examines applications in Art Unit 3736 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
